WO1993018181A1 - Sequence genique synthetique pour un peptide-signal - Google Patents
Sequence genique synthetique pour un peptide-signal Download PDFInfo
- Publication number
- WO1993018181A1 WO1993018181A1 PCT/US1993/001494 US9301494W WO9318181A1 WO 1993018181 A1 WO1993018181 A1 WO 1993018181A1 US 9301494 W US9301494 W US 9301494W WO 9318181 A1 WO9318181 A1 WO 9318181A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protein
- signal peptide
- dna molecule
- hybrid
- glucuronidase
- Prior art date
Links
- 108010076504 Protein Sorting Signals Proteins 0.000 title claims abstract description 65
- 108700005078 Synthetic Genes Proteins 0.000 title description 2
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 190
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 139
- 210000004027 cell Anatomy 0.000 claims abstract description 77
- 108020004414 DNA Proteins 0.000 claims abstract description 51
- 102000053602 DNA Human genes 0.000 claims abstract description 40
- 230000014509 gene expression Effects 0.000 claims abstract description 31
- 230000000694 effects Effects 0.000 claims abstract description 29
- 239000012634 fragment Substances 0.000 claims abstract description 26
- 238000000034 method Methods 0.000 claims abstract description 24
- 101710196023 Vicilin Proteins 0.000 claims abstract description 22
- 210000002472 endoplasmic reticulum Anatomy 0.000 claims abstract description 17
- 230000008569 process Effects 0.000 claims abstract description 13
- 230000001681 protective effect Effects 0.000 claims abstract description 8
- 230000004927 fusion Effects 0.000 claims description 15
- 108020004511 Recombinant DNA Proteins 0.000 claims description 13
- 108010060309 Glucuronidase Proteins 0.000 claims description 12
- 102000053187 Glucuronidase Human genes 0.000 claims description 12
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 11
- 239000013604 expression vector Substances 0.000 claims description 10
- 210000002288 golgi apparatus Anatomy 0.000 claims description 10
- 230000001580 bacterial effect Effects 0.000 claims description 9
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 9
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 7
- 210000002421 cell wall Anatomy 0.000 claims description 7
- 230000013595 glycosylation Effects 0.000 claims description 7
- 238000006206 glycosylation reaction Methods 0.000 claims description 7
- 239000013598 vector Substances 0.000 claims description 7
- 239000003550 marker Substances 0.000 claims description 6
- 230000002538 fungal effect Effects 0.000 claims description 5
- 239000002773 nucleotide Substances 0.000 claims description 4
- 125000003729 nucleotide group Chemical group 0.000 claims description 4
- 108010053481 Antifreeze Proteins Proteins 0.000 claims description 3
- 230000004656 cell transport Effects 0.000 claims description 3
- 108020001507 fusion proteins Proteins 0.000 claims description 2
- 102000037865 fusion proteins Human genes 0.000 claims description 2
- 230000002101 lytic effect Effects 0.000 claims description 2
- 230000003248 secreting effect Effects 0.000 claims description 2
- 241000238631 Hexapoda Species 0.000 claims 4
- ZBLQIYPCUWZSRZ-QEJZJMRPSA-N Ala-Phe-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CC1=CC=CC=C1 ZBLQIYPCUWZSRZ-QEJZJMRPSA-N 0.000 claims 3
- ARHJJAAWNWOACN-FXQIFTODSA-N Ala-Ser-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O ARHJJAAWNWOACN-FXQIFTODSA-N 0.000 claims 3
- LPBUBIHAVKXUOT-FXQIFTODSA-N Cys-Val-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CS)N LPBUBIHAVKXUOT-FXQIFTODSA-N 0.000 claims 3
- SODXFJOPSCXOHE-IHRRRGAJSA-N Met-Leu-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O SODXFJOPSCXOHE-IHRRRGAJSA-N 0.000 claims 3
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 claims 1
- 238000003306 harvesting Methods 0.000 claims 1
- 239000002581 neurotoxin Substances 0.000 claims 1
- 231100000618 neurotoxin Toxicity 0.000 claims 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims 1
- 241000196324 Embryophyta Species 0.000 description 69
- 210000001938 protoplast Anatomy 0.000 description 26
- 244000061176 Nicotiana tabacum Species 0.000 description 19
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 18
- 230000028327 secretion Effects 0.000 description 18
- YJQCOFNZVFGCAF-UHFFFAOYSA-N Tunicamycin II Natural products O1C(CC(O)C2C(C(O)C(O2)N2C(NC(=O)C=C2)=O)O)C(O)C(O)C(NC(=O)C=CCCCCCCCCC(C)C)C1OC1OC(CO)C(O)C(O)C1NC(C)=O YJQCOFNZVFGCAF-UHFFFAOYSA-N 0.000 description 14
- ZHSGGJXRNHWHRS-VIDYELAYSA-N tunicamycin Chemical compound O([C@H]1[C@@H]([C@H]([C@@H](O)[C@@H](CC(O)[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C(NC(=O)C=C2)=O)O)O1)O)NC(=O)/C=C/CC(C)C)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O ZHSGGJXRNHWHRS-VIDYELAYSA-N 0.000 description 14
- MEYZYGMYMLNUHJ-UHFFFAOYSA-N tunicamycin Natural products CC(C)CCCCCCCCCC=CC(=O)NC1C(O)C(O)C(CC(O)C2OC(C(O)C2O)N3C=CC(=O)NC3=O)OC1OC4OC(CO)C(O)C(O)C4NC(=O)C MEYZYGMYMLNUHJ-UHFFFAOYSA-N 0.000 description 14
- 210000003935 rough endoplasmic reticulum Anatomy 0.000 description 13
- 240000004713 Pisum sativum Species 0.000 description 12
- 235000010582 Pisum sativum Nutrition 0.000 description 12
- 230000009261 transgenic effect Effects 0.000 description 12
- 239000013612 plasmid Substances 0.000 description 10
- 230000032258 transport Effects 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 239000012528 membrane Substances 0.000 description 8
- 108020004999 messenger RNA Proteins 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 230000037361 pathway Effects 0.000 description 7
- 229920001184 polypeptide Polymers 0.000 description 7
- 230000001086 cytosolic effect Effects 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 5
- 230000031787 nutrient reservoir activity Effects 0.000 description 5
- 229940124276 oligodeoxyribonucleotide Drugs 0.000 description 5
- 210000003705 ribosome Anatomy 0.000 description 5
- 108010022172 Chitinases Proteins 0.000 description 4
- 102000012286 Chitinases Human genes 0.000 description 4
- 244000061456 Solanum tuberosum Species 0.000 description 4
- 235000002595 Solanum tuberosum Nutrition 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 238000012512 characterization method Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000013518 transcription Methods 0.000 description 4
- 230000035897 transcription Effects 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 3
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 3
- 241000219843 Pisum Species 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 210000000805 cytoplasm Anatomy 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 239000011536 extraction buffer Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 230000001052 transient effect Effects 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- LWTDZKXXJRRKDG-KXBFYZLASA-N (-)-phaseollin Chemical compound C1OC2=CC(O)=CC=C2[C@H]2[C@@H]1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-KXBFYZLASA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- HSHNITRMYYLLCV-UHFFFAOYSA-N 4-methylumbelliferone Chemical compound C1=C(O)C=CC2=C1OC(=O)C=C2C HSHNITRMYYLLCV-UHFFFAOYSA-N 0.000 description 2
- ARQXEQLMMNGFDU-JHZZJYKESA-N 4-methylumbelliferone beta-D-glucuronide Chemical compound C1=CC=2C(C)=CC(=O)OC=2C=C1O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ARQXEQLMMNGFDU-JHZZJYKESA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 241000701489 Cauliflower mosaic virus Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- 208000031888 Mycoses Diseases 0.000 description 2
- 241000208136 Nicotiana sylvestris Species 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 108010001267 Protein Subunits Proteins 0.000 description 2
- 102000002067 Protein Subunits Human genes 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 150000001720 carbohydrates Chemical group 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000007421 fluorometric assay Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 108091005573 modified proteins Proteins 0.000 description 2
- 102000035118 modified proteins Human genes 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 230000001254 nonsecretory effect Effects 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 210000002729 polyribosome Anatomy 0.000 description 2
- 230000004481 post-translational protein modification Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 241001157784 Cercospora nicotianae Species 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 101100310856 Drosophila melanogaster spri gene Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 241000256023 Hyalophora cecropia Species 0.000 description 1
- 108700022013 Insecta cecropin B Proteins 0.000 description 1
- 108010025815 Kanamycin Kinase Proteins 0.000 description 1
- 101710094902 Legumin Proteins 0.000 description 1
- 101000763602 Manilkara zapota Thaumatin-like protein 1 Proteins 0.000 description 1
- 101000763586 Manilkara zapota Thaumatin-like protein 1a Proteins 0.000 description 1
- 101000966653 Musa acuminata Glucan endo-1,3-beta-glucosidase Proteins 0.000 description 1
- 230000004988 N-glycosylation Effects 0.000 description 1
- 241000208133 Nicotiana plumbaginifolia Species 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 229910019142 PO4 Chemical group 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 101710096342 Pathogenesis-related protein Proteins 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 101710163504 Phaseolin Proteins 0.000 description 1
- 108010059820 Polygalacturonase Proteins 0.000 description 1
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
- 241000269913 Pseudopleuronectes americanus Species 0.000 description 1
- 230000004570 RNA-binding Effects 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 108020004566 Transfer RNA Proteins 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 241000269368 Xenopus laevis Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000008162 cell wall modification Effects 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 244000038559 crop plants Species 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- NEKNNCABDXGBEN-UHFFFAOYSA-L disodium;4-(4-chloro-2-methylphenoxy)butanoate;4-(2,4-dichlorophenoxy)butanoate Chemical compound [Na+].[Na+].CC1=CC(Cl)=CC=C1OCCCC([O-])=O.[O-]C(=O)CCCOC1=CC=C(Cl)C=C1Cl NEKNNCABDXGBEN-UHFFFAOYSA-L 0.000 description 1
- 230000003241 endoproteolytic effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000001723 extracellular space Anatomy 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 101150054900 gus gene Proteins 0.000 description 1
- 210000000087 hemolymph Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000010189 intracellular transport Effects 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 210000000287 oocyte Anatomy 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 101150072645 pea gene Proteins 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- LWTDZKXXJRRKDG-UHFFFAOYSA-N phaseollin Natural products C1OC2=CC(O)=CC=C2C2C1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Chemical group 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical group [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 108010082527 phosphinothricin N-acetyltransferase Proteins 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 238000004161 plant tissue culture Methods 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000013606 secretion vector Substances 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 210000000783 smooth endoplasmic reticulum Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000011191 terminal modification Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000010474 transient expression Effects 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8221—Transit peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Definitions
- the present invention relates generally to recombinantly produced proteins in plant cells and a process of transporting such proteins into the endoplasmic reticulum of plant cells, where they can subsequently be transported outside the cell or deposited in specific intracellular compartments.
- the endoplasmic reticulum plays a number of important functions.
- the smooth endoplasmic reticulum which lacks ribosomes, provides a site for synthesis and metabolism of fatty acids and phospholipids.
- the rough endoplasmic reticulum is studded with ribosomes which participate in the synthesis of cytoplasmic, membrane, and organelle proteins as well as in the synthesis of proteins to be secreted from the cell.
- RNA polymerase activates a control region on the gene which transcribes the DNA (i.e. encoded information) into messenger RNA. Transcription is ended by one or more "stop" codons on the gene.
- the messenger RNA is then translated into the encoded protein at the ribosomes bound to the rough endoplasmic reticulum.
- a growing polypeptide emerges from the ribosome, passes through the membrane of the rough endoplasmic reticulum, and accumulates in its lumen or central cavity.
- Proteins destined for direct transport include a lead signal peptide section, which is what directs the protein to enter the endoplasmic reticulum, and is then cleaved from the remainder of the protein after such entrance.
- proteins and membrane constituents are directed to their appropriate destinations. This is achieved by enzymatically modifying the proteins with a "tag" (e.g. , a carbohydrate or phosphate residue) to direct them to vesicles which transport the modified proteins outside the cell (or to intracellular compartments) .
- a "tag” e.g. , a carbohydrate or phosphate residue
- vicilins the major storage protein of developing legume seeds.
- Vicilins are synthesized as prepro-vi ⁇ ilins on membrane-bound ribosomes of the rough endoplasmic reticulum.
- prepro- vicilins pass into the lumen of the rough endoplasmic reticulum, their signal peptides are removed, as recognized by T.J.V. Higgins and D. Spencer, "Precursor forms of Pea Gene Encoding Vicilin Subunits," 67 Plant Phvsiol 205-11 (1981) , which is hereby incorporated by reference.
- the resulting peptides may then undergo various post-translational modifications.
- the protein in the lumen of the endoplasmic reticulum or in the Golgi complex, the protein may undergo glycosylation so that it is ready for intracellular transport, as recognized by B.S.L. Beevers, "Glycoprotein Metabolism in the Cotyledons of Pisum Sativum During Development and Germination," 57 Plant Ph ⁇ siol. 93-97 (1976) and R.A. Davey and .F. Dudman, "The Carbohydrate of Storage Glycoproteins from Seeds of Pisum Sativum: Characterization and Distribution of Component Polypeptides," 6 Aust. J. Plant Physiol.
- Boulter "Characterization of the Storage Protein Subunits Synthesized in vitro by Polyribosomes and RNA from Developing Pea (Pisum sativum L.), I.” 148 Le umin. Planta 49- 56 (1980); R.R.D. Croy, J.A. Gatehouse, I.M. Evans, and D. Boulter, "Characterization of the Storage Protein Subunits Synthesized in vitro by Polyribosomes and RNA from Developing Pea (Pisum sativum L.), II.” 148 Vicilin Planta 57-63 (1980); J.A. Gatehouse, R.R.D. Croy, H. Morton, M. Tyler, and D.
- heterologous genes i.e. DNA that encodes proteins not ordinarily produced by the host organism containing that vehicle.
- a heterologous gene is first inserted into a closing vector, such as a plasmid.
- the vector is then transfected into the host cells, which are thereafter transformed.
- the tranformed cells then multiply to increase the population containing copies of the gene to be expressed in the host cell for production of a protein foreign to that cell.
- the signal peptides were derived from gene fragments encoding for the pathogenesis-related protein 16(sPRI) , a protein secreted in tobacco mosaic virus-infected tobacco leaves-, and the prepro-peptide of cecropin B(sCEC), a peptide secreted into the hemolymph of the insect Hyalophora cecropia. It was found that the total level of enzyme expression was lower in secretion constructs (with the signal peptide sequence) than for unmodified genes which encoded for the enzyme alone.
- genes encoding for a hybrid protein consisting of a signal peptide sequence fused to another protein for the purpose of secretion is thus well known in plant cells.
- these signal peptides are not satisfactory, because they do not achieve high expression levels and, in fact, decrease the expression level of the desired proteins. Accordingly, the need exists for effective signal peptide sequences which can maintain or enhance high expression levels of desired proteins in plant cells.
- the present invention relates to a process of transporting a desired protein to the endoplasmic reticulum of plant cells for secretion.
- This process utilizes a DNA molecule encoding for a hybrid protein which includes a first protein containing a signal peptide, as described below, which was derived from the putative published sequence for the vicilin signal peptide, or its homologs, or any fragments thereof fused to a second protein which confers an extracellular protective or other desired effect in plant cells.
- the second protein may be a protein or fragment thereof which imparts bacterial, fungal, or freeze resistance outside the cell walls of plant cells transformed with an expression system in which that DNA molecule is cloned.
- the DNA molecule encoding the hybrid protein of the present invention may be cloned into an expression vector (e.g., a plasmid) to form a recombinant DNA expression system. This system is then transfected into plant cells. The plant cells of the present invention are then transformed and grown in a suitable medium to increase the number of such transformed cells. The transformed cells thus express the DNA encoding the hybrid protein of the present invention.
- the hybrid protein includes the signal peptide described below, its homologs, or any fragment thereof which directs transport of the second protein into the endoplasmic reticulum. The signal peptide is cleaved off upon entry into the rough endoplasmic reticulum.
- the second protein which is the protein of interest, is further modified in the endoplasmic reticulum lumen or in the Golgi complex and then secreted outside the plant cell or otherwise transported within the cell. Any plant cell transformed with this recombinant DNA expression system may then secrete the desired protein.
- This system can be used to secrete proteins which will condition resistance to bacteria, fungi, or frost, or will affect plant cell walls or function as markers or tags or color factors.
- Figure IB shows the 5' end of the hybrid gene encoding for the signal peptide and j8-glucuronidase, and the corresponding amino acids.
- Figure 2A is a graph showing the 0-glucuronidase activity for transformed leaf cells of transgenic tobacco plants.
- Figure 2B is a graph showing the ⁇ -glucuronidase activity for transformed root cells of transgenic tobacco plants.
- Figure 3A shows a chart of the distribution of transient
- Figure 3B shows a chart of the distribution of transient j3-glucuronidase activity in transformed tobacco protoplasts in the presence of tunicamycin.
- Figure 4 is a chart showing the total transient ⁇ - glucuronidase activity (pooled from all fractions) in transformed protoplasts in the presence of tunicamycin.
- the present invention relates to a process of transporting proteins to the endoplasmic reticulum of plant cells for secretion or other targeting within the cell.
- This process utilizes a DNA molecule encoding a hybrid protein.
- the hybrid protein includes a first part of the protein which contains a signal peptide derived from a putative sequence for the vicilin protein, its homologs, or any fragments thereof.
- This first protein is fused to a second protein which confers an extracellular protective effect in plant calls or any other desired effect such as for marking, color, cell wall modification, etc.
- the signal peptide, its homologs, or fragments thereof is present to enable the hybrid protein to enter the cell's transport pathway via the endoplasmic reticulum.
- the signal peptide Upon entry into the lumen, the signal peptide is cleaved from the second protein in the same fashion as the vicilin signal peptide would be separated from the vicilin protein to which it is fused in nature.
- the second protein can then be processed in the Golgi complex or in the endoplasmic reticulum lumen for extracellular secretion or transport within the cell.
- the DNA molecule of the present invention encodes for an amino acid signal sequence substantially corresponding to the sequence:
- the second protein is a protein or fragment thereof which imparts a resistance to bacteria, fungi, or freezing or any other desired effect.
- the synthetic sequence derived from the Pisum vicilin signal peptide is effective in producing a hybrid protein which includes and carries a second protein into the cell transport path. As a result the resistance provided by the second protein is imparted to plants extracellularly (i.e. outside the cell wall, particularly to extracellular surfaces of the plant cell walls) .
- proteins which may impart extracellular bacterial resistance to plants include lytic proteins. See, e.g., L. Destefano-Beltran, "Enhancing Bacterial and Fungal Disease Resistance in Plants: Application to Potato," Molecular Biology of the Potato, p. 205-21 (1990) , which is hereby incorporated by reference.
- proteins which may impart extracellular fungal resistance to plants include chitinases and glucanases. See, e.g., C. Castresana, "Tissue-Specific and Pathogen-Induced Regulation of a Nicotiana plumbaginifolia ⁇ - 1,3-Glucanase Gene," 2 The Plant Cell. 1131-43 (1990); J. Neuhaus, "High-level Expression of a Tobacco Chitanase Gene in Nicotiana sylvestris . Susceptibility of Transgenic Plants to Cercospora Nicotianae Infection," 16 Plant Molec. Biol. 141-51 (1991) ; and L. Destefano-Beltran, "Enhancing Bacterial and Fungal Disease Resistance in Plants: Application to Potato,” Molecular Biology of the Potato, p. 205-21 (1990), all of which are hereby incorporated by reference.
- proteins which may impart extracellular antifreezing capability in plants include numerous fish antifreeze peptides. See, e.g., P.L. Davies, "Antifreeze Protein Genes of the Winter Flounder," 259 J. Biol. Chem. 9241-47 (1984) , which is hereby incorporated by reference.
- the second protein may include polygalacturonase, /3-glucuronidase, other marker proteins, and their homologs, fragments, or portions thereof.
- jS-glucuronidase primarily serves as an example.
- the gene encoding for jS-glucuronidase is a widely used marker gene having a well known sequence and known to be useful in forming N-terminal fusions. See, e.g., R.A. Jefferson, "Assaying Chimeric Genes in Plants: The GUS Gene Fusion System," 5 Plant Molecular Biology Reporter. 387-405 (1987) and R.A. Jefferson, "j ⁇ -Glucuronidase from Escherichia coli as a Gene-fusion Marker," 83 Proc.
- the polypeptide formed from the fusion of the first protein to the second protein is a hybrid in that the first and second proteins are not normally joined in nature. Likewise, the corresponding portions of the DNA molecule encoding each of these proteins makes the DNA molecule a hybrid.
- the portion of the DNA molecule encoding the first protein is fused in proper orientation and correct reading frame to that part of the DNA molecule encoding the second protein.
- a linker sequence connects these portions of the DNA molecule.
- the expression vector into which this fusion DNA molecule is inserted includes a promoter sequence which functions to regulate polypeptide expression.
- a wide variety of promoters may be utilized, such as the 35S promoter of cauliflower mosaic virus.
- the DNA molecule encoding for the hybrid protein of the present invention is inserted into an expression system to which the DNA molecule is heterologous (i.e., not normally present) .
- the heterologous DNA molecule is inserted into the expression system or vector in proper orientation and correct reading frame.
- plasmids include pBI426 and pMON316, preferably pMON316.
- the expression system of the present invention can be used to transform virtually any crop plant cell under suitable conditions. Such cells are transformed with the DNA molecule of the present invention by conventional procedures. Cells transformed in accordance with the present invention can be grown in vitro in a suitable medium to produce the desired second protein. This protein can then be harvested or recovered by conventional purification techniques. Alternatively, transformed cells can be regenerated into whole plants such that secreted proteins impart desired characteristics to the intact plants.
- DNA molecule of the present invention Regardless of whether the DNA molecule of the present invention is expressed in intact plants or in culture, expression of the desired protein follows essentially the same basic mechanism. Specifically, transcription of the DNA molecule is initiated by the binding of RNA polymerase to the DNA molecule's promoter. During transcription, movement of the RNA polymerase along the DNA molecule forms messenger RNA. As a result, the DNA molecule that encodes for the hybrid protein of the present invention is transcribed into the corresponding messenger RNA. This messenger RNA then moves to the ribosomes of the rough endoplasmic reticulum which, with transfer RNA, translates the messenger RNA into the hybrid protein of the present invention.
- the resulting hybrid protein passes into the lumen of the rough endoplasmic reticulum.
- the signal sequence i.e., the first protein, its homolog, or a fragment thereof
- the second protein having the ability to confer desired effects will continue to advance into the lumen in an unfused state.
- This protein is then modified by glycosylation in the lumen or in Golgi complex.
- the modified protein is then secreted by the Golgi complex to a location outside the host cell or is transported within the cell to a specific site.
- Complementary oligodeoxyribonucleotides of each segment were then annealed by combining 0.2 nmole of each, and incubating the mixture at 90°C for 10 minutes, at 65°C for 2 hours, and at room temperature (i.e. 32°C) overnight.
- the resulting DNA fragment was then purified from a polyacrylamide gel and used for construction of plant j8-glucuronidase-secretion vector through a multiple-step procedure.
- the gene encoding jS-glucuronidase was excised from the plas id pBI101.3 (Clontech Laboratories, Inc.) with Hindlll+SstI , and ligated into the vector p ⁇ Cll ⁇ . See, J. Vieira and J. Messing, "Production of Single-stranded Plasmid DNA," 153 Methods Enzymol 3-11 (1987) , which is hereby incorporated by , reference, that had been cut with Hindlll+SstI .
- a Kpnl linker ( ⁇ '-GGGTACCC) and a Hindlll linker (5'CCAAGCTTGG) were inserted into the unique Hindlll and Smal sites upstream of the gene encoding ⁇ -glucuronidase in the resulting p ⁇ C118- ⁇ -glucuronidase in the resulting p ⁇ C118- ⁇ -glucuronidase plasmid.
- the purified signal peptide fragment was then fused in-frame to the N-terminus of the gene encoding ⁇ -glucuronidase to form pUC118- ⁇ -glucuronidasel, by replacing the Kpnl-Hindlll multi-cloning fragment of the modified p ⁇ cll8- ⁇ -glucuronidase with the assembled signal peptide-encoding fragment.
- the fusion region of the hybrid gene in pUC118- ⁇ -glucuronidasel ( Figure 1) was sequenced by the dideoxy chain-termination method of F. Sanger, S. Nicklen, and A.R. Coulson, "DNA Sequencing with Chain-terminating Inhibitors," 74 Proc. Natl. Acad. Sci. USA 5463-67 (1977), the disclosure of which is hereby incorporated by reference, using the universal M13 primer.
- the KpnI-EcoRI fragment coding for the signal peptide//3-glucuronidase fusion was isolated from pUcll8- ⁇ -glucuronidasel and cloned into the plant expression vector pMON316. See, S.G. Rogers, H.J.
- Plasmid pM0N316- ⁇ -glucuronidasel-2 was similarly constructed, according to the above-described procedures in an independent cloning experiment.
- the 3-glucuronidase-encoding sequence was closed into pMON316 in both orientations to generate positive (pMON316- ⁇ -glucuronidase (+) ) and negative (p ⁇ fON31t5-3-grIu ⁇ uronidase (-) ) controls for expression of the gene encoding for
- the fusion gene was then placed under the 35S promoter of cauliflower mosaic virus in a plant expression vector, and introduced into tobacco protoplasts for transient expression, and into tobacco leaf discs/NTl cells for stable transformation, using conventional recombinant technology procedures.
- Leaf discs from in vitro grown plantlets were transformed using an improved biolistic device of G.N. Ye, M. Daniell, and J.C. Sanford, "Optimization of Delivery of Foreign Gene into Higher Plant Chloroplasts," 15 Plant Mol. Biol. 809-19 (1990) , which is hereby incorporated by reference, and transformants were selected on kanamycin medium following two days of incubation on non-selective medium.
- Transgenic plants from leaf discs were regenerated from shoots after transfer to a hormone-free tobacco medium. 20 ⁇ g tunicamycin per ml was added to the culture medium to inhibit glycosylation of the fusion -glucuronidase.
- Leaf or root extracts were prepared by grinding in the extraction buffer (50 mM Tris-HCl, pH 7.5/0.15 mg phenylmethylsulfonyl fluoride/0.3 mg dithiothreitol/0.3 mg bovine serum albumin, all per ml) and removing the cell debris by centrifugation.
- the /3-glucuronidase fluorometric assay described by J.H. Gould and R.M. Smith "A Non-destructive Assay for 0-glucuronidase in the Media of Plant Tissue Cultures," 7 Plant Mol. Biol. Rep.
- GUS(-) and GUS(+) represent the plants transformed with pMON316- ⁇ -glucuronidase (-) and pMON316- ⁇ -glucuronidase (+) , respectively, while GUSl-1 and GUS1-2 represent plants transformed with the similar vicilin(s) signal peptide/3-glucuronidase-encoding constructs pMON316- ⁇ -glucuronidasel-l and pMON316- ⁇ -glucuronidase 1-2.
- pMON316- ⁇ -glucuronidase (-) Since the fusion region of the hybrid gene encoding for jS-glucuronidase was sequenced, and confirmed to be correct, the absence of 8-glucuronidase activity in the plants containing the fusion gene must be attributed to the interference of gene expression by the addition of the signal peptide sequence. Alternatively, the gene fusion or post-translational modification of the fusion protein in the transport pathway could cause loss of /3-glucuronidase activity.
- Protoplasts were prepared from leaves derived from seedlings of N. tabacum var Havana cv 423 grown in vitro at low light intensity, generally as described by J.I. Negy and P. Maliga, "Callus Induction and Plant Regeneration from Mesophyll Protoplasts of Nicotiana Sylvestris.” 78 Z. convincedvsiol 453-55 (1976) , which disclosure is hereby incorporated by reference, with some modifications. Briefly, the sliced leaves were digested in an isolation medium containing 1.25% Cellulase RIO and 0.4% Macerozyme RIO (Karlan Chemical Corporation, Torrance, CA) at 26°C overnight.
- the protoplasts at the interface were transferred to new tubes and washed with W5 solution.
- the isolated protoplasts were transformed with the plasmid constructs described above using the polyethylene glycol method of Negrutiu.
- the transformed protoplasts were then cultured at the final density of lxlO 6 protoplasts/ml in the culture medium (containing 20 ⁇ g tunicamycin/ml where indicated) at 26°C in the dark.
- the transformed tobacco protoplasts were fractionated into extracellular, cytoplasmic and membrane-associated fractions about 50 hours after the polyethylene glycol-mediated transformation.
- the extracellular fraction (the culture medium) was collected as supernatant from the protoplast cultures following centrifugation at lOOxg for 5 minutes.
- the pelleted protoplasts were washed once in W5 solution and lysed by osmotic shock in an appropriate volume of extraction buffer
- the transport system appears to become saturated or partially blocked, resulting in accumulation of 3-glucuronidase in the cytoplasm.
- the protoplasts transiently expressing the hybrid gene produced 10-30 fold more j8-glucuronidase protein (Fig. 4) than the transgenic plants containing the same construct (Fig. 2) .
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Botany (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
L'invention se rapporte à un procédé de transport d'une protéine désirée dans le réticulum endoplasmique de cellules végétales à l'intérieur ou à l'extérieur de la cellule. Dans ce procédé, on utilise une molécule d'ADN codant une protéine hybride. Ladite protéine hybride codée se compose d'une première protéine comprenant un peptide-signal dérivé d'un présumé peptide comprenant un peptide-signal de vicilline, de son homologue, ou d'un morceau de celui-ci, et d'une seconde protéine qui produit un effet protecteur extracellulaire ou un autre effet désiré dans les cellules végétales. Cette molécule d'ADN peut être insérée dans un système d'expression qui peut ensuite être utilisé pour transformer les cellules qui dirigeront la seconde protéine désirée dans son système de transport.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85142992A | 1992-03-13 | 1992-03-13 | |
US07/851,429 | 1992-03-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1993018181A1 true WO1993018181A1 (fr) | 1993-09-16 |
Family
ID=25310749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1993/001494 WO1993018181A1 (fr) | 1992-03-13 | 1993-02-19 | Sequence genique synthetique pour un peptide-signal |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO1993018181A1 (fr) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006501818A (ja) * | 2002-07-23 | 2006-01-19 | デルタ バイオテクノロジー リミテッド | 遺伝子およびポリペプチド配列 |
WO2019241315A1 (fr) | 2018-06-12 | 2019-12-19 | Obsidian Therapeutics, Inc. | Constructions régulatrices dérivées de pde5 et procédés d'utilisation en immunothérapie |
WO2020086742A1 (fr) | 2018-10-24 | 2020-04-30 | Obsidian Therapeutics, Inc. | Régulation de protéine accordable par er |
WO2020185632A1 (fr) | 2019-03-08 | 2020-09-17 | Obsidian Therapeutics, Inc. | Compositions d'anhydrase carbonique humaine 2 et procédés de régulation accordable |
WO2020252405A1 (fr) | 2019-06-12 | 2020-12-17 | Obsidian Therapeutics, Inc. | Compositions de ca2 et procédés de régulation ajustable |
WO2020252404A1 (fr) | 2019-06-12 | 2020-12-17 | Obsidian Therapeutics, Inc. | Compositions de ca2 et procédés de régulation accordable |
WO2021046451A1 (fr) | 2019-09-06 | 2021-03-11 | Obsidian Therapeutics, Inc. | Compositions et méthodes de régulation de protéine accordable dhfr |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4940840A (en) * | 1984-03-26 | 1990-07-10 | Dna Plant Technology Corporation | Novel chitinase-producing bacteria and plants |
-
1993
- 1993-02-19 WO PCT/US1993/001494 patent/WO1993018181A1/fr active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4940840A (en) * | 1984-03-26 | 1990-07-10 | Dna Plant Technology Corporation | Novel chitinase-producing bacteria and plants |
Non-Patent Citations (5)
Title |
---|
GENE, Volume 99, No. 1, issued 01 March 1991, M. DE LOOSE et al., "The Extensin Signal Peptide Allows Secretion of a Heterologous Protein form Protoplasts", pages 95-100. * |
NUCLEIC ACIDS RESEARCH, Volume 11, No. 8, issued 1983, "The Vicilin Gene Family of Pea (Pisum Sativum L.): A Complete cDNA Coding Sequence for Preprovicilin", pages 2367-2380. * |
PLANT MOLECULAR BIOLOGY, Volume 11, issued 1988, T.J.V. HIGGINS et al., "The Sequence of a Pea Vicilin Gene and its Expression in Transgenic Tobacco Plants", pages 683-695. * |
PLANT PHYSIOLOGY, Volume 91, issued 1989, P. LUND et al., "Bacterial Chitanse is Modified and Secreting in Transgenic Tobacco", pages 130-135. * |
THE PLANT CELL, Volume 1, issued March 1989, G. ITURRIAGA et al., "Endoplasmic Reticulum Targeting and Glycosylation of Hybrid Proteins in Transgenic Tobacco", pages 381-390. * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006501818A (ja) * | 2002-07-23 | 2006-01-19 | デルタ バイオテクノロジー リミテッド | 遺伝子およびポリペプチド配列 |
EP2390333A1 (fr) * | 2002-07-23 | 2011-11-30 | Novozymes Biopharma DK A/S | Polypeptides avec une pre-séquence de sécrétion de la sérum albumine humaine modifiée avec rendement de sécrétion amelioré |
US8258102B2 (en) | 2002-07-23 | 2012-09-04 | Novozymes Biopharma Dk A/S | Gene and polypeptide sequences |
US9133265B2 (en) | 2002-07-23 | 2015-09-15 | Novozymes Biopharma Dk A/S | Gene and polypeptide sequences |
WO2019241315A1 (fr) | 2018-06-12 | 2019-12-19 | Obsidian Therapeutics, Inc. | Constructions régulatrices dérivées de pde5 et procédés d'utilisation en immunothérapie |
WO2020086742A1 (fr) | 2018-10-24 | 2020-04-30 | Obsidian Therapeutics, Inc. | Régulation de protéine accordable par er |
WO2020185632A1 (fr) | 2019-03-08 | 2020-09-17 | Obsidian Therapeutics, Inc. | Compositions d'anhydrase carbonique humaine 2 et procédés de régulation accordable |
WO2020252405A1 (fr) | 2019-06-12 | 2020-12-17 | Obsidian Therapeutics, Inc. | Compositions de ca2 et procédés de régulation ajustable |
WO2020252404A1 (fr) | 2019-06-12 | 2020-12-17 | Obsidian Therapeutics, Inc. | Compositions de ca2 et procédés de régulation accordable |
WO2021046451A1 (fr) | 2019-09-06 | 2021-03-11 | Obsidian Therapeutics, Inc. | Compositions et méthodes de régulation de protéine accordable dhfr |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bednarek et al. | A carboxyl-terminal propeptide is necessary for proper sorting of barley lectin to vacuoles of tobacco. | |
US5650307A (en) | Production of heterologous proteins in plants and plant cells | |
US5650554A (en) | Oil-body proteins as carriers of high-value peptides in plants | |
EP0392225B1 (fr) | Plantes transgéniques résistantes aux maladies | |
JP5517309B2 (ja) | コラーゲン生産植物及びその作成方法及びその使用 | |
Kavanagh et al. | Targeting a foreign protein to chloroplasts using fusions to the transit peptide of a chlorophyll a/b protein | |
US5665579A (en) | Invertase genes and uses thereof | |
CA2110772A1 (fr) | Promoteur ltp2 ayant une activite aleurone specifique | |
AU2002333330A1 (en) | Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies | |
JP2004516003A (ja) | 植物ゴムおよび他のヒドロキシプロリンに富んだ糖タンパク質に関する合成遺伝子 | |
Saalbach et al. | The vacuolar targeting signal of the 2S albumin from Brazil nut resides at the C terminus and involves the C-terminal propeptide as an essential element | |
FI120266B (fi) | Öljyonteloproteiinit arvokkaiden peptidien kantajina kasveissa | |
Bosch et al. | A trout growth hormone is expressed, correctly folded and partially glycosylated in the leaves but not the seeds of transgenic plants | |
AU2005308922B2 (en) | Protein isolation and purification | |
US20080010697A1 (en) | Methods of Expressing Heterologous Protein in Plant Seeds Using Monocot Non Seed-Storage Protein Promoters | |
WO1993018181A1 (fr) | Sequence genique synthetique pour un peptide-signal | |
EP1003840A1 (fr) | Genes syntetiques pour gommes vegetales | |
Napier et al. | Trafficking of wheat gluten proteins in transgenic tobacco plants: γ-gliadin does not contain an endoplasmic reticulum-retention signal | |
US20070039073A1 (en) | Novel synthetic genes for plant gums | |
Pang et al. | Use of the signal peptide of Pisum vicilin to translocate β-glucuronidase in Nicotiana tabacum | |
EP2518081B1 (fr) | Procédé pour la production et la purification de protéines polymères dans des plantes transgéniques | |
US7557264B2 (en) | Gossypium hirsutum tissue-specific promoters and their use | |
US20040117874A1 (en) | Methods for accumulating translocated proteins | |
US5525713A (en) | DNA encoding polypeptides enabling sorting of proteins to vacuoles in plants | |
Le | The BURP domain protein family of Arabidopsis: a novel component related to seed development |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
122 | Ep: pct application non-entry in european phase |